• Filing Date: 2020-08-03
  • Form Type: 10-Q
  • Description: Quarterly report
v3.20.2
Condensed Consolidated Statements of Changes in Stockholders' (Deficit) Equity - USD ($)
$ in Thousands
Common Stock
Series B
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2018 18,767,619 240,861      
Beginning balance, amount at Dec. 31, 2018 $ 2 $ 0 $ 15,518 $ (12,064) $ 3,456
Stock-based compensation     238   238
Issuance of warrants in conjunction with notes payable     706   $ 706
Exercise of cashless warrants in exchange for common stock 14,566       0
Common stock issued in OpenALPR Technology acquisition, shares 600,000        
Common stock issued in OpenALPR Technology acquisition, amount     397   $ 397
Preferred stock dividends       (230) (230)
Accretion of Series A preferred stock     (363)   (363)
Net loss (7,802) (7,802)
Ending balance, shares at Jun. 30, 2019 19,382,185 240,861      
Ending balance, amount at Jun. 30, 2019 $ 2 $ 0 16,496 (20,094) (3,596)
Beginning balance, shares at Mar. 31, 2019 19,367,619 240,861      
Beginning balance, amount at Mar. 31, 2019 $ 2 $ 0 16,505 (15,052) 1,455
Stock-based compensation     175   175
Exercise of cashless warrants in exchange for common stock 14,566        
Preferred stock dividends       (115) (115)
Accretion of Series A preferred stock     (184)   (184)
Net loss (4,927) (4,927)
Ending balance, shares at Jun. 30, 2019 19,382,185 240,861      
Ending balance, amount at Jun. 30, 2019 $ 2 $ 0 16,496 (20,094) (3,596)
Beginning balance, shares at Dec. 31, 2019 21,595,653 240,861      
Beginning balance, amount at Dec. 31, 2019 $ 2 $ 0 19,371 (28,408) (9,035)
Stock-based compensation     337   337
Exercise of cashless warrants in exchange for common stock 43,218        
Exercise of warrants in exchange for common stock 555,000        
Exercise of warrants in exchange for common stock, amount     411   411
Issuance of common stock pursuant to at the market offering net, shares 538,967        
Issuance of common stock pursuant to at the market offering net, amount     2,177   2,177
Exercise of warrants related to series A preferred stock, shares 57,963        
Exercise of warrants related to series A preferred stock, amount     60   60
Issuance upon exercise of stock options, shares 151,745        
Issuance upon exercise of stock options, amount     242   242
Preferred stock dividends       (230) (230)
Accretion of Series A preferred stock     (418)   (418)
Net loss (4,406) (4,406)
Ending balance, shares at Jun. 30, 2020 22,942,546 240,861      
Ending balance, amount at Jun. 30, 2020 $ 2 $ 0 22,180 (33,044) (10,862)
Beginning balance, shares at Mar. 31, 2020 22,768,757 240,861      
Beginning balance, amount at Mar. 31, 2020 $ 2 $ 0 21,959 (32,311) (10,350)
Stock-based compensation     166   166
Issuance of common stock pursuant to at the market offering net, shares 2,237        
Issuance of common stock pursuant to at the market offering net, amount     8   8
Exercise of warrants related to series A preferred stock, shares 21,101        
Exercise of warrants related to series A preferred stock, amount     22   22
Issuance upon exercise of stock options, shares 150,451        
Issuance upon exercise of stock options, amount     237   237
Preferred stock dividends       (115) (115)
Accretion of Series A preferred stock     (212)   (212)
Net loss (618) (618)
Ending balance, shares at Jun. 30, 2020 22,942,546 240,861      
Ending balance, amount at Jun. 30, 2020 $ 2 $ 0 $ 22,180 $ (33,044) $ (10,862)